Chronic myeloid leukemia in the imatinib era

BJ Druker - Seminars in hematology, 2003 - Elsevier
The results of imatinib (Gleevec)(formerly STI571) therapy for chronic myeloid leukemia
(CML) have continued to improve and have surpassed almost everyone's predictions …

Chronic myeloid leukemia in the imatinib era.

BJ Druker - Seminars in Hematology, 2003 - europepmc.org
The results of imatinib (Gleevec)(formerly STI571) therapy for chronic myeloid leukemia
(CML) have continued to improve and have surpassed almost everyone's predictions …

Chronic myeloid leukemia in the imatinib era

BJ Druker - Seminars in hematology, 2003 - pubmed.ncbi.nlm.nih.gov
The results of imatinib (Gleevec)(formerly STI571) therapy for chronic myeloid leukemia
(CML) have continued to improve and have surpassed almost everyone's predictions …

Chronic myeloid leukemia in the imatinib era

BJ Druker - Seminars in Hematology, 2003 - infona.pl
The results of imatinib (Gleevec)(formerly STI571) therapy for chronic myeloid leukemia
(CML) have continued to improve and have surpassed almost everyone's predictions …

[PDF][PDF] Seminars in HEMATOLOGY

BJ Druker - Semin Hematol, 2003 - Citeseer
The assumption from the preceding paragraph is that imatinib as a single agent, at 400 mg
per day, while highly efficacious, may not be a curative therapy for the majority of CML …

[引用][C] Chronic myeloid leukemia in the imatinib era

BJ DRUKER - Seminars in hematology, 2003 - pascal-francis.inist.fr
Chronic myeloid leukemia in the imatinib era CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …

Chronic myeloid leukemia in the imatinib era

BJ Druker - Seminars in hematology, 2003 - ohsu.elsevierpure.com
The results of imatinib (Gleevec)(formerly STI571) therapy for chronic myeloid leukemia
(CML) have continued to improve and have surpassed almost everyone's predictions …

Chronic myeloid leukemia in the imatinib era

BJ Druker - Seminars in Hematology, 2003 - infona.pl
The results of imatinib (Gleevec)(formerly STI571) therapy for chronic myeloid leukemia
(CML) have continued to improve and have surpassed almost everyone's predictions …

[引用][C] Chronic myeloid leukemia in the imatinib era

BJ DRUKER - Seminars in hematology, 2003 - Elsevier